A citation-based method for searching scientific literature

Jason Beiko, Dima Suki, Kenneth R Hess, Benjamin D Fox, Vincent Cheung, Matthew Cabral, Nicole Shonka, Mark R Gilbert, Raymond Sawaya, Sujit S Prabhu, Jeffrey Weinberg, Frederick F Lang, Kenneth D Aldape, Erik P Sulman, Ganesh Rao, Ian E McCutcheon, Daniel P Cahill. Neuro Oncol 2014
Times Cited: 265







List of co-cited articles
652 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
53

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
33

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
27

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
26

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
24

An extent of resection threshold for newly diagnosed glioblastomas.
Nader Sanai, Mei-Yin Polley, Michael W McDermott, Andrew T Parsa, Mitchel S Berger. J Neurosurg 2011
878
24

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
M Lacroix, D Abi-Said, D R Fourney, Z L Gokaslan, W Shi, F DeMonte, F F Lang, I E McCutcheon, S J Hassenbusch, E Holland,[...]. J Neurosurg 2001
21


Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Tomohiro Kawaguchi, Yukihiko Sonoda, Ichiyo Shibahara, Ryuta Saito, Masayuki Kanamori, Toshihiro Kumabe, Teiji Tominaga. J Neurooncol 2016
76
19

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
15

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Walter Stummer, Uwe Pichlmeier, Thomas Meinel, Otmar Dieter Wiestler, Friedhelm Zanella, Hans-Jürgen Reulen. Lancet Oncol 2006
14

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
Maarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, Winand N M Dinjens, Peggy N Atmodimedjo, Johan M Kros, Marion Smits, Renske Gahrmann, Geert-Jan Rutten, Jeroen B Verheul,[...]. Neuro Oncol 2018
131
14

An integrated genomic analysis of human glioblastoma multiforme.
D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia,[...]. Science 2008
13

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Matthew M Grabowski, Pablo F Recinos, Amy S Nowacki, Jason L Schroeder, Lilyana Angelov, Gene H Barnett, Michael A Vogelbaum. J Neurosurg 2014
212
13

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
Justin S Smith, Edward F Chang, Kathleen R Lamborn, Susan M Chang, Michael D Prados, Soonmee Cha, Tarik Tihan, Scott Vandenberg, Michael W McDermott, Mitchel S Berger. J Clin Oncol 2008
797
13

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
13

Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
Annette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, Jacob Young, Seunggu J Han, Pranathi Chunduru, Yalan Zhang, Joanna J Phillips, Anny Shai, Marisa Lafontaine,[...]. JAMA Oncol 2020
109
13

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
11

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
Changho Choi, Sandeep K Ganji, Ralph J DeBerardinis, Kimmo J Hatanpaa, Dinesh Rakheja, Zoltan Kovacs, Xiao-Li Yang, Tomoyuki Mashimo, Jack M Raisanen, Isaac Marin-Valencia,[...]. Nat Med 2012
497
11

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
11

Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial.
Christian Senft, Andrea Bink, Kea Franz, Hartmut Vatter, Thomas Gasser, Volker Seifert. Lancet Oncol 2011
465
10

Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Timothy J Brown, Matthew C Brennan, Michael Li, Ephraim W Church, Nicholas J Brandmeir, Kevin L Rakszawski, Akshal S Patel, Elias B Rizk, Dima Suki, Raymond Sawaya,[...]. JAMA Oncol 2016
380
10

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
Kaisorn L Chaichana, Ignacio Jusue-Torres, Rodrigo Navarro-Ramirez, Shaan M Raza, Maria Pascual-Gallego, Aly Ibrahim, Marta Hernandez-Hermann, Luis Gomez, Xiaobu Ye, Jon D Weingart,[...]. Neuro Oncol 2014
261
10

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
Roger Stupp, Sophie Taillibert, Andrew Kanner, William Read, David Steinberg, Benoit Lhermitte, Steven Toms, Ahmed Idbaih, Manmeet S. Ahluwalia, Karen Fink,[...]. JAMA 2017
755
10

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.
C Houillier, X Wang, G Kaloshi, K Mokhtari, R Guillevin, J Laffaire, S Paris, B Boisselier, A Idbaih, F Laigle-Donadey,[...]. Neurology 2010
351
10

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Brigitta G Baumert, Monika E Hegi, Martin J van den Bent, Andreas von Deimling, Thierry Gorlia, Khê Hoang-Xuan, Alba A Brandes, Guy Kantor, Martin J B Taphoorn, Mohamed Ben Hassel,[...]. Lancet Oncol 2016
243
9

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, Arnab Chakravarti, Mark R Gilbert, Geoffrey R Barger, Stephen Coons, Peter Ricci, Dennis Bullard, Paul D Brown,[...]. N Engl J Med 2016
490
9

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Federico Pessina, Pierina Navarria, Luca Cozzi, Anna Maria Ascolese, Matteo Simonelli, Armando Santoro, Elena Clerici, Marco Rossi, Marta Scorsetti, Lorenzo Bello. J Neurooncol 2017
58
15


Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.
Biqi Zhang, Ken Chang, Shakti Ramkissoon, Shyam Tanguturi, Wenya Linda Bi, David A Reardon, Keith L Ligon, Brian M Alexander, Patrick Y Wen, Raymond Y Huang. Neuro Oncol 2017
131
9

Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas.
Asgeir S Jakola, Kristin S Myrmel, Roar Kloster, Sverre H Torp, Sigurd Lindal, Geirmund Unsgård, Ole Solheim. JAMA 2012
373
8

Glioma extent of resection and its impact on patient outcome.
Nader Sanai, Mitchel S Berger. Neurosurgery 2008
805
8


IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.
Philipp Kickingereder, Felix Sahm, Alexander Radbruch, Wolfgang Wick, Sabine Heiland, Andreas von Deimling, Martin Bendszus, Benedikt Wiestler. Sci Rep 2015
164
8

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Mark E Oppenlander, Andrew B Wolf, Laura A Snyder, Robert Bina, Jeffrey R Wilson, Stephen W Coons, Lynn S Ashby, David Brachman, Peter Nakaji, Randall W Porter,[...]. J Neurosurg 2014
148
8

The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.
Toral Patel, Evan D Bander, Rachael A Venn, Tiffany Powell, Gustav Young-Min Cederquist, Peter M Schaefer, Luis A Puchi, Akbarshakh Akhmerov, Shahiba Ogilvie, Anne S Reiner,[...]. Neurosurgery 2018
34
23

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Michele Ceccarelli, Floris P Barthel, Tathiane M Malta, Thais S Sabedot, Sofie R Salama, Bradley A Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano M Pagnotta,[...]. Cell 2016
8

IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.
Qi SongTao, Yu Lei, Gui Si, Ding YanQing, Han HuiXia, Zhang XueLin, Wu LanXiao, Yao Fei. Cancer Sci 2012
179
8

Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence.
Zeynettin Akkus, Issa Ali, Jiří Sedlář, Jay P Agrawal, Ian F Parney, Caterina Giannini, Bradley J Erickson. J Digit Imaging 2017
78
10


Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms.
Songtao Qi, Lei Yu, Hezhen Li, Yanghui Ou, Xiaoyu Qiu, Yanqing Ding, Huixia Han, Xuelin Zhang. Oncol Lett 2014
104
8

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.
Walter Stummer, Hanns-Jürgen Reulen, Thomas Meinel, Uwe Pichlmeier, Wiebke Schumacher, Jörg-Christian Tonn, Veit Rohde, Falk Oppel, Bernd Turowski, Christian Woiciechowsky,[...]. Neurosurgery 2008
645
7

The definition of primary and secondary glioblastoma.
Hiroko Ohgaki, Paul Kleihues. Clin Cancer Res 2013
573
7

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Marc Sanson, Yannick Marie, Sophie Paris, Ahmed Idbaih, Julien Laffaire, François Ducray, Soufiane El Hallani, Blandine Boisselier, Karima Mokhtari, Khe Hoang-Xuan,[...]. J Clin Oncol 2009
710
7

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Christian Hartmann, Bettina Hentschel, Wolfgang Wick, David Capper, Jörg Felsberg, Matthias Simon, Manfred Westphal, Gabriele Schackert, Richard Meyermann, Torsten Pietsch,[...]. Acta Neuropathol 2010
520
7

Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
David Mampre, Jeffrey Ehresman, Gabriel Pinilla-Monsalve, Maria Alejandra Gamboa Osorio, Alessandro Olivi, Alfredo Quinones-Hinojosa, Kaisorn L Chaichana. Br J Neurosurg 2018
28
25


European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017
529
7

Surgical resection versus watchful waiting in low-grade gliomas.
A S Jakola, A J Skjulsvik, K S Myrmel, K Sjåvik, G Unsgård, S H Torp, K Aaberg, T Berg, H Y Dai, K Johnsen,[...]. Ann Oncol 2017
128
7

Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging.
Ken Chang, Harrison X Bai, Hao Zhou, Chang Su, Wenya Linda Bi, Ena Agbodza, Vasileios K Kavouridis, Joeky T Senders, Alessandro Boaro, Andrew Beers,[...]. Clin Cancer Res 2018
150
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.